Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margien L Seinen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
The Lancet. Gastroenterology & Hepatology|April 14, 2017
A plea for TDM-based optimisation for treatment of Crohn's diseaseMargien L Seinen, Nanne K de Boer
European Journal of Gastroenterology & Hepatology|August 1, 2018
Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol-thiopurine cotherapyMelek Simsek, Margien L Seinen, Nanne K H de Boer
Expert Opinion on Drug Metabolism & Toxicology|March 21, 2019
Key insights from therapeutic drug monitoring in Crohn's disease patientsMargien L Seinen, Nanne K De Boer, Adriaan A van Bodegraven
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2013
Reply: To PMID 23333660Margien L Seinen, Nanne K H De Boer, Adriaan A van Bodegraven
Cancer Research|February 9, 2013
Oxidation-mediated DNA crosslinking contributes to toxicity of 6-thioguanine in human cells -- letterNanne K H de Boer, Dirk P van Asseldonk, Margien L Seinen, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|October 6, 2010
Dosing 6-thioguanine in inflammatory bowel disease: expert-based guidelines for daily practiceMargien L Seinen, Dirk P van Asseldonk, Chris J J Mulder, et al.
Molecular Diagnosis & Therapy|September 9, 2016
Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine TherapyMargien L Seinen, Geerten P van Nieuw Amerongen, Nanne K H de Boer, et al.
Journal of Crohn'S & Colitis|January 21, 2012
Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatmentDirk P van Asseldonk, Margien L Seinen, Nanne K H de Boer, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 25, 2020
The continuous rediscovery and the benefit-risk ratio of thioguanine, a comprehensive reviewAhmed B Bayoumy, Melek Simsek, Margien L Seinen, et al.
Therapeutic Drug Monitoring|May 10, 2016
Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel DiseaseBerrie Meijer, Margien L Seinen, Niek N W Leijte, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
The Lancet. Gastroenterology & Hepatology|April 14, 2017
A plea for TDM-based optimisation for treatment of Crohn's diseaseMargien L Seinen, Nanne K de Boer
European Journal of Gastroenterology & Hepatology|August 1, 2018
Nodular regenerative hyperplasia in inflammatory bowel disease patients with allopurinol-thiopurine cotherapyMelek Simsek, Margien L Seinen, Nanne K H de Boer
Expert Opinion on Drug Metabolism & Toxicology|March 21, 2019
Key insights from therapeutic drug monitoring in Crohn's disease patientsMargien L Seinen, Nanne K De Boer, Adriaan A van Bodegraven
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 15, 2013
Reply: To PMID 23333660Margien L Seinen, Nanne K H De Boer, Adriaan A van Bodegraven
Cancer Research|February 9, 2013
Oxidation-mediated DNA crosslinking contributes to toxicity of 6-thioguanine in human cells -- letterNanne K H de Boer, Dirk P van Asseldonk, Margien L Seinen, et al.
Journal of Gastrointestinal and Liver Diseases : JGLD|October 6, 2010
Dosing 6-thioguanine in inflammatory bowel disease: expert-based guidelines for daily practiceMargien L Seinen, Dirk P van Asseldonk, Chris J J Mulder, et al.
Molecular Diagnosis & Therapy|September 9, 2016
Rac Attack: Modulation of the Small GTPase Rac in Inflammatory Bowel Disease and Thiopurine TherapyMargien L Seinen, Geerten P van Nieuw Amerongen, Nanne K H de Boer, et al.
Journal of Crohn'S & Colitis|January 21, 2012
Hepatotoxicity associated with 6-methyl mercaptopurine formation during azathioprine and 6-mercaptopurine therapy does not occur on the short-term during 6-thioguanine therapy in IBD treatmentDirk P van Asseldonk, Margien L Seinen, Nanne K H de Boer, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 25, 2020
The continuous rediscovery and the benefit-risk ratio of thioguanine, a comprehensive reviewAhmed B Bayoumy, Melek Simsek, Margien L Seinen, et al.
Therapeutic Drug Monitoring|May 10, 2016
Clinical Value of Mercaptopurine After Failing Azathioprine Therapy in Patients With Inflammatory Bowel DiseaseBerrie Meijer, Margien L Seinen, Niek N W Leijte, et al.
Pageof 3